Identifying risk factors for brain metastasis in breast cancer patients: Implication for a vigorous surveillance program

被引:16
作者
Chow, Lorraine [1 ]
Suen, Dacita [1 ]
Ma, Kwok Kuen [1 ]
Kwong, Ava [1 ]
机构
[1] Univ Hong Kong, Dept Surg, Div Breast Surg, Pok Fu Lam, Hong Kong, Peoples R China
关键词
brain metastasis; breast cancer; HER2; trastuzumab; whole-brain irradiation; TRASTUZUMAB;
D O I
10.1016/j.asjsur.2015.03.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Brain metastasis occurs in 10-15% of metastatic breast cancer patients and is associated with poor prognosis. This study aims to identify tumor characteristics of primary breast cancer, which are related to brain metastases in Hong Kong Chinese patients. Methods: A retrospective study of patients with invasive breast cancer receiving treatment in a university hospital from January 2001 to December 2008 was performed. The clinicopathological factors of patients with brain metastases were analyzed and compared with those who had no brain metastasis. Risk factors for brain metastasis were identified by univariate analysis first and then by multivariate analysis. Results: A total of 912 patients with invasive breast cancer were treated during the study period. Of these, 30 patients were found to have distant metastases to brain. Patients with brain metastases had more breast tumors of higher histological grade (Grade III, 78.9% vs. 30.2%; p = 0.001). Their tumors also had a significantly higher rate of negative estrogen receptors (78.9% vs. 30.2%, p = 0.001). On multivariate analysis, only high tumor grading was found to be predictive of developing brain metastasis. Conclusion: Chinese breast cancer patients with brain metastasis were more likely to have high-grade tumors and negative estrogen receptor status. A more vigorous surveillance program for the central nervous system should be considered for this group of patients. Copyright (C) 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:220 / 223
页数:4
相关论文
共 15 条
[1]   Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission [J].
Aupérin, A ;
Arriagada, R ;
Pignon, JP ;
Le Péchoux, C ;
Gregor, A ;
Stephens, RJ ;
Kristjansen, PEG ;
Johnson, BE ;
Ueoka, H ;
Wagner, H ;
Aisner, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :476-484
[2]   From the trastuzumab era to new target therapies: beyond revolution [J].
Barni, S. ;
Petrelli, F. ;
Cabiddiu, M. ;
Cazzaniga, M. E. ;
Cremonesi, M. .
ANNALS OF ONCOLOGY, 2007, 18 :1-4
[3]   Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].
Bendell, JC ;
Domchek, SM ;
Burstein, HJ ;
Harris, L ;
Younger, J ;
Kuter, I ;
Bunnell, C ;
Rue, M ;
Gelman, R ;
Winer, E .
CANCER, 2003, 97 (12) :2972-2977
[4]   Lapatinib in breast cancer [J].
Bilancia, D. ;
Rosati, G. ;
Dinota, A. ;
Germano, D. ;
Romano, R. ;
Manzione, L. .
ANNALS OF ONCOLOGY, 2007, 18 :26-30
[5]  
Carty N J, 1995, Eur J Surg Oncol, V21, P607, DOI 10.1016/S0748-7983(95)95176-8
[6]   Breast cancer brain metastases [J].
Cheng, Xiaoyun ;
Hung, Mien-Chie .
CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) :635-643
[7]   Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world [J].
Kamangar, Farin ;
Dores, Graca M. ;
Anderson, William F. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (14) :2137-2150
[8]   CNS metastases in breast cancer [J].
Lin, NU ;
Bellon, JR ;
Winer, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (17) :3608-3617
[9]  
Montemurro Filippo, 2005, Clin Breast Cancer, V6, P77, DOI 10.3816/CBC.2005.n.011
[10]   Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer [J].
Swain, Sandra M. ;
Baselga, Jose ;
Kim, Sung-Bae ;
Ro, Jungsil ;
Semiglazov, Vladimir ;
Campone, Mario ;
Ciruelos, Eva ;
Ferrero, Jean-Marc ;
Schneeweiss, Andreas ;
Heeson, Sarah ;
Clark, Emma ;
Ross, Graham ;
Benyunes, Mark C. ;
Cortes, Javier .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (08) :724-734